EWPI Financials 07/16/2014 03:16:36 Emerging Worl
Post# of 5
Emerging World Pharma, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses
Research and Development - -
Sales, General and Admin. 121 77
Non-Recurring Items 18 1
Other - -
Operating Income (139) (79)
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax (139) (79)
Interest Expense 272 177
Earnings Before Tax (410) (255)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (410) (255)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (410) (255)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (410) (255)